Zhengye Biotechnology Operating Income Over Time
| ZYBT Stock | 0.90 0.07 7.22% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Zhengye Biotechnology Performance and Zhengye Biotechnology Correlation. Is there potential for Pharmaceuticals market expansion? Will Zhengye introduce new products? Factors like these will boost the valuation of Zhengye Biotechnology. Anticipated expansion of Zhengye directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Zhengye Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.34) | Return On Assets |
Zhengye Biotechnology's market price often diverges from its book value, the accounting figure shown on Zhengye's balance sheet. Smart investors calculate Zhengye Biotechnology's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Zhengye Biotechnology's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Zhengye Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zhengye Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zhengye Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare Zhengye Biotechnology and related stocks such as Incannex Healthcare, Cardiol Therapeutics, and Pro Dex Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IXHL | (147 K) | (3.4 M) | (10 M) | (6.3 M) | (1.9 M) | (577.2 K) | (16.1 M) | (2.4 M) | (2 M) | (2.8 M) | (8.2 M) | (10.2 M) | (13.6 M) | (45 M) | (23.8 M) | (21.4 M) | (20.3 M) |
| CRDL | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (7.4 M) | (10.9 M) | (16.2 M) | (30.6 M) | (30.5 M) | (22.5 M) | (40.3 M) | (36.2 M) | (34.4 M) |
| PDEX | (500 K) | (1.4 M) | (1.9 M) | (814 K) | (902 K) | 526 K | 2.7 M | 2.4 M | 5 M | 7.1 M | 5.1 M | 5.1 M | 5.8 M | 7.2 M | 10.7 M | 12.3 M | 12.9 M |
| SRZN | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (25.1 M) | (32.8 M) | (54.4 M) | (44.3 M) | (45.8 M) | (25.5 M) | (23 M) | (24.1 M) |
| SERA | (16.6 M) | (16.6 M) | (16.6 M) | (16.6 M) | (16.6 M) | (16.6 M) | (16.6 M) | (16.6 M) | (16.6 M) | (16.6 M) | (18 M) | (35.4 M) | (45.7 M) | (39.8 M) | (36.6 M) | (33 M) | (34.6 M) |
| EXOZ | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.8 M) | (5.9 M) | (5.3 M) | (5.1 M) |
| ATOS | (122.9 K) | (3.4 M) | (5.1 M) | (10.8 M) | (12.2 M) | (12.8 M) | (7.2 M) | (7.2 M) | (11.4 M) | (17.3 M) | (14.6 M) | (20.5 M) | (27.7 M) | (31.4 M) | (27.6 M) | (24.9 M) | (23.6 M) |
| APYX | (219.5 K) | (18 K) | 1 M | (3.7 M) | (5.8 M) | (7 M) | (3.8 M) | (5.3 M) | (13.6 M) | (20.9 M) | (20.1 M) | (14.4 M) | (23.6 M) | (17.3 M) | (18.8 M) | (17 M) | (16.1 M) |
| TIL | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (6.6 M) | (33.6 M) | (155.6 M) | (206.2 M) | (159.2 M) | (73.5 M) | (66.2 M) | (69.5 M) |
| ONCY | (577.4 K) | (28.7 M) | (36.7 M) | (23.9 M) | (18.8 M) | (13.9 M) | (15.3 M) | (15.6 M) | (16.7 M) | (20.7 M) | (19 M) | (20.9 M) | (20.7 M) | (25 M) | (35 M) | (31.5 M) | (29.9 M) |
Zhengye Biotechnology and related stocks such as Incannex Healthcare, Cardiol Therapeutics, and Pro Dex Operating Income description
Operating Income is the amount of profit realized from Zhengye Biotechnology operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Zhengye Biotechnology Holding is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Zhengye Biotechnology Holding | ZYBT |
| Classification | Biotech |
| Business Address | No1 Lianmeng Road, |
| Exchange | NASDAQ Exchange |
null 0.9
Additional Tools for Zhengye Stock Analysis
When running Zhengye Biotechnology's price analysis, check to measure Zhengye Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhengye Biotechnology is operating at the current time. Most of Zhengye Biotechnology's value examination focuses on studying past and present price action to predict the probability of Zhengye Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhengye Biotechnology's price. Additionally, you may evaluate how the addition of Zhengye Biotechnology to your portfolios can decrease your overall portfolio volatility.